Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,411.20
(
-2.35%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,137.96
(
-0.30%
)
News Focus
News Focus
Post# of 257300
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

nicksdad

Send PM Follow Ignore
Followers 0
Posts 5
Boards Moderated 0
Alias Born 10/19/2003

nicksdad

Re: None

Wednesday, 10/22/2003 12:52:38 AM

Wednesday, October 22, 2003 12:52:38 AM

Post# of 257300
Somewhat concerned that the Foundation Fighting Blindness website does not include any information on GENR's recent clinical trials with Squalamine. I see many others mentioned, including one for Combretastatin that is currently recruiting. Any logical reason for GENR's absence? Check out the link to AMD setion:

http://www.blindness.org/disease/clinictrial_detail.asp?id=16&type=2

I'd truly appreciate any thoughts from the wonderful folks on this board.

TIA,


Frank
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today